Come up with a name for your new list and we'll add to it:
NanoVector raised a round of funding on January 12, 2009. Investors include
National Science Foundation.
NanoVector is a pre-clinical stage therapeutic drug company developing the world's first commercially viable biologic nanoparticle-based therapeutic drug delivery system. The NanoVector breakthrough t…